Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA Capital/Financing Update 2020

Nov 10, 2020

3633_rns_2020-11-10_d62b9fd3-c7ab-42ea-9e73-987671cf6646.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

IDEX Biometrics - Private placement successfully completed, raising NOK 70 million

IDEX Biometrics - Private placement successfully completed, raising NOK 70 million

IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint

identification and authentications solutions, has successfully conducted a

private placement of new shares (the "Private Placement").

The gross proceeds of the Private Placement amounts to NOK 70 million by issue

of 42.5 million new shares at NOK 1.65 per share. The Private Placement took

place 9 November 2020 after close of Oslo Børs.

The additional funds are expected to meet the Company's capital requirements in

the medium term.The net proceeds from the Private Placement will be used to fund

growth opportunities and for general corporate purposes.

Vince Graziani, CEO, IDEX Biometrics, said: "This additional capital will enable

IDEX to deliver on our commitments to current customers and new customers when

we are moving to large scale commercialization. This investment confirms the

potential of IDEX's fingerprint sensor technology in the biometric payment cards

market."

IDEX is an international company traded on Oslo Børs. The Company intends to

list American Depositary Shares ("ADSs") representing its ordinary shares, on

the Nasdaq Stock Market, this in addition to its current listing on Oslo Børs.

The new shares are issued under the board's current authorization to issue

shares as resolved by the Company's annual general meeting held on 15 May 2020.

The shares were placed at 3.1% premium on the closing price of the Company's

shares on 9 November 2020, to Norwegian and international investors and existing

shareholders of the Company, as well as board members and members of management.

The Company's board believes that the Private Placement is an appropriate

funding mechanism at the current time and is in the best interest of the Company

and all of its shareholders. The board considers it is appropriate to waive the

existing shareholders' preferential right to subscribe for the Offer Shares.

The subscription amount must be paid by 20 November 2020. The new shares will be

issued as soon as practicable after payment and registration of the capital

increase with the Norwegian Register of Business Enterprises. Following the

Private Placement, the Company will have a share capital amounting to NOK

124,592,824.65 divided into 830618831 shares at NOK 0.15 nominal value per

share.

The following primary insiders subscribed to shares in the Private Placement:

Chair Morten Opstad subscribed to 100,000 shares. Following the Private

Placement, Mr. Opstad and close associates hold 7,398,916 shares and no other

rights to shares in IDEX.

Deputy chair Larry Ciaccia subscribed to 150,000 shares. Following the Private

Placement, Mr. Ciaccia holds 271,563 shares and 600,000 subscription rights to

shares in IDEX.

Board member Deborah Davis subscribed to 50,000 shares. Following the Private

Placement, Ms. Davis holds 564,479 shares and no other rights to shares in IDEX.

Board member Hanne Høvding subscribed to 25,000 shares. Following the Private

Placement, Ms. Høvding holds 487,778 shares and no other rights to shares in

IDEX.

Board member Steve Skaggs subscribed to 100,000 shares. Following the Private

Placement, Mr. Skaggs holds 764,909 shares and no other rights to shares in

IDEX.

Board observer Tom Quindlen subscribed to 275,000 shares. Following the Private

Placement, Mr. Quindlen holds 275,000 shares and no other rights to shares in

IDEX.

CEO Vince Graziani subscribed to 150,000 shares. Following the Private

Placement, Mr. Graziani holds 1,035,000 shares and 5,000,000 subscription rights

to shares in IDEX.

CFO Derek D'Antilio subscribed to 125,000 shares. Following the Private

Placement, Mr. D'Antilio holds 611,479 shares and 2,000,000 subscription rights

to shares in IDEX.

CTO Anthony Eaton subscribed to 30,000 shares. Following the Private Placement,

Mr. Eaton holds 211,041 shares and 1,452,800 subscription rights to shares in

IDEX.

VP Finance Erling Svela subscribed to 90,000 shares. Following the Private

Placement, Mr. Svela holds 320,162 shares and 1,061,200 subscription rights to

shares in IDEX.

For further information contact:

Marianne Bøe, Investor Relations

E-mail: [email protected]

Tel: + 47 918 00186

Derek D'Antilio, Chief Financial Officer

E-mail: [email protected]

Tel: +1 978 273 1344

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of

fingerprint identification technologies offering simple, secure and personal

touch-free authentication for all.  We help people make payments, prove their

identity, gain access to information, unlock devices or gain admittance to

buildings. We invent, engineer, and commercialize these secure and safe yet

incredibly user-friendly solutions.  Our total addressable market represents a

fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

IMPORTANT INFORMATION

This announcement is not and does not form a part of any offer to sell, or a

solicitation of an offer to purchase any securities. The distribution of this

announcement and other information may be restricted by law in certain

jurisdictions. Copies of this announcement are not being made and may not be

distributed or sent into any jurisdiction in which such distribution would be

unlawful or would require registration or other measures. Persons into whose

possession this announcement or such other information should come are required

to inform themselves about and to observe any such restrictions.

The securities referred to in this announcement have not been and will not be

registered under the U.S. Securities Act of 1933, as amended (the "Securities

Act"), and accordingly may not be offered or sold in the United States absent

registration or an applicable exemption from the registration requirements of

the Securities Act and in accordance with applicable U.S. state securities

laws.  There will be no public offer of the securities referred to in this

announcement in the United States. Any public offering of securities to be made

in the United States will be made by means of a prospectus that may be obtained

from the issuer or the selling security holder and that will contain detailed

information about the Company and management, as well as financial statements.

This information is subject to the disclosure requirements pursuant to Section

5-12 the Norwegian Securities Trading Act